By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlaxoSmithKline (North Carolina)  

Formerly Glaxo Wellcome
5 Moore Drive, P.O. Box 13398
Research Triangle Park  North Carolina  27709  U.S.A.
Phone: 888-825-5249 Fax:


GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.

GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer.

Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.

GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products.

The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders.

Based on 2003 Annual Results, GSK had sales of £21.4 billion ($35.2 billion) and profit before tax of £6.7 billion ($11 billion). Total pharmaceutical turnover grew 5% to just over £18 billion ($29 billion).

GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Over 42,000 employees work at 91 manufacturing sites in 38 countries and over 16,000 are in R&D.

GSK R&D is based at 24 sites in seven countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.4bn/$4bn.

Last Updated: 03-22-04

Key Statistics

Ownership: Public

Web Site: GlaxoSmithKline (North Carolina)
Employees: 6500
Symbol: GSK.L

Company News
ADHD Drugs To Have Stronger Warning; Include Novartis International AG (NVS)'s Dexedrine And GlaxoSmithKline Biologicals (GSK)'s Ritalin 8/22/2006 8:23:53 AM
GlaxoSmithKline (GSK) Release: FDA Approves ZOFRAN(R) For Use In Children As Young As One Month Of Age10/19/2005 5:13:09 PM
Hoffmann-La Roche (New Jersey) (RHHBY) And GlaxoSmithKline (GSK) Annouce FDA Approves Once-Monthly Boniva(R) For Osteoporosis First-Ever Monthly Single Tablet For Any Disease10/19/2005 5:13:07 PM
Ministry Of Health, Labor And Welfare Grants Priority Review To GlaxoSmithKline (GSK) For Zefix10/19/2005 5:12:46 PM
GlaxoSmithKline Consumer Healthcare Launches Suit To Stop Misleading Marketing Of Unproven Herbal Smoking Cessation Therapy10/19/2005 5:12:40 PM
GlaxoSmithKline (GSK) HIV Drug Gets Approval10/19/2005 5:12:31 PM
Flamel Technologies (FLML) Announces Completion Of A Commercial Supply Agreement With GlaxoSmithKline (GSK) For Drug In Phase III Trials10/19/2005 5:12:30 PM
Neurocrine Biosciences, Inc. (NBIX) Announces Initiation Of Phase I Trial With CRF1 Antagonist For Anxiety And Depression10/19/2005 5:12:27 PM
GlaxoSmithKline (GSK) Acquires Full Marketing And Development Rights For BEXXAR Worldwide10/19/2005 5:12:26 PM
GlaxoSmithKline (GSK) Launches Hepsera Oral Antiviral Drug For Chronic Hepatitis B Infection10/19/2005 5:12:25 PM